FNY Investment Advisers’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $660K | Sell |
86,744
-94,256
| -52% | -$717K | 0.28% | 102 |
|
|
2025
Q1 | $590K | Buy |
181,000
+50,750
| +39% | +$165K | 0.36% | 69 |
|
|
2024
Q4 | $586K | Sell |
130,250
-17,669
| -12% | -$79.5K | 0.3% | 77 |
|
|
2024
Q3 | $409K | Sell |
147,919
-11,023
| -7% | -$30.5K | 0.2% | 113 |
|
|
2024
Q2 | $543K | Buy |
158,942
+125,442
| +374% | +$429K | 0.36% | 51 |
|
|
2024
Q1 | $181 | Buy |
+33,500
| New | +$181 | 0.11% | 133 |
|